WallStSmart

Enhabit Inc. (EHAB)vsFresenius Medical Care Corporation (FMS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 1724% more annual revenue ($19.43B vs $1.06B). FMS leads profitability with a 4.8% profit margin vs -0.3%. FMS earns a higher WallStSmart Score of 58/100 (C).

EHAB

Hold

39

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 5.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

FMS

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EHAB.

FMSUndervalued (+68.5%)

Margin of Safety

+68.5%

Fair Value

$76.29

Current Price

$22.69

$53.60 discount

UndervaluedFair: $76.29Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EHAB1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
12.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.748/10

Growing faster than its price suggests

Areas to Watch

EHAB4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

EPS GrowthGrowth
2.9%4/10

2.9% earnings growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Market CapQuality
$706.91M3/10

Smaller company, higher risk/reward

FMS4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.5%3/10

ROE of 7.5% — below average capital efficiency

Profit MarginProfitability
4.8%3/10

4.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : EHAB

The strongest argument for EHAB centers on Price/Book.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.74 suggests the stock is reasonably priced for its growth.

Bear Case : EHAB

The primary concerns for EHAB are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : FMS

The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

EHAB profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.

EHAB carries more volatility with a beta of 0.96 — expect wider price swings.

EHAB is growing revenue faster at 1.9% — sustainability is the question.

FMS generates stronger free cash flow (620M), providing more financial flexibility.

Bottom Line

FMS scores higher overall (58/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Enhabit Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Enhabit, Inc. provides home health and hospice services in the United States.

Visit Website →

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?